Evidence map›Paper›PMID 42249692›Full record

ArticlePopulation health management2026

Point-of-Care A1C and Time from Test to Communication of Results in Primary Care.

Cecilia E W Nicol, Joselyne E Aucapina, Cordelia Lee, Pamela Mariano, Judy Tung, Jennifer I Lee, Mangala Rajan, Andrea Card, Monika M Safford, Lisa M Kern

Abstract read
In one paragraph

Article in Population health management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cecilia E W NicolWeill Cornell Medicine, New York, New York, USA.ORCID 0009-0003-4173-6655
Joselyne E AucapinaWeill Cornell Medicine, New York, New York, USA.
Cordelia LeeWeill Cornell Medicine, New York, New York, USA.
Pamela MarianoWeill Cornell Medicine, New York, New York, USA.
Judy TungWeill Cornell Medicine, New York, New York, USA.
Jennifer I LeeWeill Cornell Medicine, New York, New York, USA.
Mangala RajanWeill Cornell Medicine, New York, New York, USA.
Andrea CardWeill Cornell Medicine, New York, New York, USA.
Monika M SaffordWeill Cornell Medicine, New York, New York, USA.
Lisa M KernWeill Cornell Medicine, New York, New York, USA.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002384
6 · The paper itself

Abstract

Although patients with uncontrolled diabetes (A1C ≥ 9%) frequently visit their primary care physicians' offices, their diabetes medication is not always changed or intensified at those visits, a pattern described as "therapeutic inertia." One potential solution is the use of point-of-care fingerstick hemoglobin A1C (A1C), which provides results in minutes, rather than venous A1C, which takes days. However, point-of-care A1C is not consistently used in current practice. The authors sought to determine the effectiveness of a systematic nurse-based intervention for implementing point-of-care A1C testing among patients with uncontrolled diabetes. They conducted a before-and-after experimental trial to determine the effect of point-of-care A1C testing on therapeutic inertia in a hospital-based clinic in New York, NY, in 2024-2025. They compared the frequency of any clinical action taken and the time to communication of results to patients before vs. after intervention implementation, using chi-squared and

Indexed as

CommunicationDiabetes MellitusGlycated HemoglobinPoint-of-Care SystemsPoint-of-Care TestingPrimary Health CareAdherence InterventionsAgedFemaleHumansMaleMiddle AgedNew YorkTime FactorsGlycated Hemoglobindiabetespreventive medicinequality measurement

Identifiers

PMID42249692
PMCPMC13374563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.